Cours Satsuma Pharmaceuticals, Inc.
Actions
STSA
US80405P1075
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 63 | 01/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Director/Board Member | 64 | 08/06/23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01/06/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,51 % | 104 Md | |
+3,22 % | 97,42 Md | |
+1,86 % | 22,2 Md | |
-16,53 % | 21,23 Md | |
-8,49 % | 18,33 Md | |
-42,33 % | 16,35 Md | |
-20,09 % | 15,06 Md | |
+5,47 % | 13,98 Md | |
+28,85 % | 11,66 Md |